Suramin (Antrypol)
Jump to navigation
Jump to search
Mechanism of action
Antiparasitic with mechanism of action unclear.
Diseases for which it was used
History of changes in FDA indication
- This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.
Also known as
- Brand name: Antrypol